Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis
Journal of Oncology Pharmacy Practice - United States
doi 10.1177/1078155219839458
Full Text
Open PDFAbstract
Available in full text
Date
March 29, 2019
Authors
Publisher
SAGE Publications